Mary Wilson
Well-known member
Published: 28 September 2024
https://doi.org/10.3390/ijms251910465
Carriero, F.; Rubino, V.; Gelzo, M.; Scalia, G.; Raia, M.; Ciccozzi, M.; Gentile, I.; Pinchera, B.; Castaldo, G.; Ruggiero, G.; et al.
Abstract
The emergence of COronaVIrus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presented a global health challenge since its identification in December 2019. With clinical manifestations ranging from mild respiratory symptoms to severe multi-organ dysfunction, COVID-19 continues to affect populations worldwide. The complex interactions between SARS-CoV-2 variants and the human immune system are crucial for developing effective therapies, vaccines, and preventive measures. Understanding these immune responses highlights the intricate nature of COVID-19 pathogenesis. This retrospective study analyzed, by flow cytometry approach, a cohort of patients infected with SARS-CoV-2 during the initial pandemic waves from 2020 to 2021. It focused on untreated individuals at the time of hospital admission and examined the presence of T[SUB]R3-56[/SUB] cells in their immune profiles during the anti-viral immune response. Our findings provide additional insights into the complex immunological dynamics of SARS-CoV-2 infection and highlight the potential role of T[SUB]R3-56[/SUB] cells as crucial components of the immune response. We suggest that T[SUB]R3-56[/SUB] cells could serve as valuable biomarkers for identifying more severe cases of COVID-19, aiding in the assessment and management of the disease.
https://www.mdpi.com/1422-0067/25/19/10465
https://doi.org/10.3390/ijms251910465
Carriero, F.; Rubino, V.; Gelzo, M.; Scalia, G.; Raia, M.; Ciccozzi, M.; Gentile, I.; Pinchera, B.; Castaldo, G.; Ruggiero, G.; et al.
Abstract
The emergence of COronaVIrus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presented a global health challenge since its identification in December 2019. With clinical manifestations ranging from mild respiratory symptoms to severe multi-organ dysfunction, COVID-19 continues to affect populations worldwide. The complex interactions between SARS-CoV-2 variants and the human immune system are crucial for developing effective therapies, vaccines, and preventive measures. Understanding these immune responses highlights the intricate nature of COVID-19 pathogenesis. This retrospective study analyzed, by flow cytometry approach, a cohort of patients infected with SARS-CoV-2 during the initial pandemic waves from 2020 to 2021. It focused on untreated individuals at the time of hospital admission and examined the presence of T[SUB]R3-56[/SUB] cells in their immune profiles during the anti-viral immune response. Our findings provide additional insights into the complex immunological dynamics of SARS-CoV-2 infection and highlight the potential role of T[SUB]R3-56[/SUB] cells as crucial components of the immune response. We suggest that T[SUB]R3-56[/SUB] cells could serve as valuable biomarkers for identifying more severe cases of COVID-19, aiding in the assessment and management of the disease.
https://www.mdpi.com/1422-0067/25/19/10465